Nearly Half of New Cancer Therapies Approved by FDA Lack Randomized Clinical Trial Evidence & Only Prolong Life by Weeks
A large number of cancer therapies are approved by the FDA without randomized clinical trials and only increase median survival by 2.4 months, according to a new review article published in the Journal of the American Medical Association (JAMA). This may come as a surprise and disappointment considering the urgent goals of cancer research to…